The MIBO statement for studies reporting mesenchymal stem cells was developed in 2016. The MIBO stem cells checklist consists of twelve sections split into 25 statements. These statements include details of the study design, recipients, injury, intervention, donors, tissue harvest and processing, cell culture, MSC characteristics, delivery, post-operative care and outcome assessment. MIBO stem cells aims to ensure that mesenchymal stem cells trials are more accurately interpreted and more easily replicated.


  • Facebook App Icon
  • Twitter App Icon
  • Google+ App Icon